by Rod Raynovich | Sep 2, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-3 9/11..Selective SMID biotechs ran up today along with the mid day reversal in the tech stocks showing speculative interest remains in the market. Watch ARKG and XBI for strength. Some big movers this week: ADPT,CRBU CRMD,DNLI, NTRA, ROIV,VCYT. But SUPN was...
by Raynovich Rod | Aug 28, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Life Science Sector Update August 2024 Nothing seems be happening lately in the market as we wait for Nvidia earnings. It’s the slowest week of the year, we are at the market top and most earnings reports are good. And FED Chairman Powell recently indicated a...
by Raynovich Rod | Aug 5, 2024 | 2024 Rayno Biopharmaceuticals Portfolio
8/12/24…COMING SOON MARKET DATA ON BIOTECH STOCKS UPDATE on Large Caps since ASCO. Did you buy or add to ABBV, GILD,LLY? Which SMID biotechs still have Momentum? ADPT,CPRX,NTRA etc. ===== Update-2 8/9/24 10:45 a EDT: EVH soars on revenue beat with an increase...
by Raynovich Rod | Jul 29, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
8/2 …10a EST: Port in the storm in this volatile rotation ? healthcare stocks: ABT,INSP, MRK, REGN, UNH etc. 8/1..3:10P EST…Massive reversal down for chip stocks and tech in general. Only green on my screen are large cap biopharmas: ABBV, GILD, LLY,...
by Raynovich Rod | Jul 22, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-1 JY 24…Healthcare Stocks held up well during today’s technology sell-off. NASDAQ stocks took a big hit today with the QQQ down 3.59%.We can say it was caused by the Google earnings report as technology analysts tried to read beyond the actual...
by Raynovich Rod | Jul 15, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio
Update-3 JY 19…3:15 EST.. Market still down little but coming back. CNBC offering positive comments on biotech, tape looks better. I had a nervous trigger finger yesterday selling my profitable NTRA and its coming back today but Ill wait to get back...
by Raynovich Rod | Jul 8, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-3 …7/11…SMID biotechs rally on a big rotation day out of MEGA Cap tech.XBI up 2.67% “kissing” the $98 level.Nibble on our Life Science trading list as it is another “green screen ” day. Even the IBB broke through $140 today...
by Raynovich Rod | Jun 10, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Healthcare stocks
Update-4…6/29….I’m back but I did not miss much in biotech trades, but a lot of “3 day wonders'” you know stocks that get momentum then quickly fade. The XBI is still holding above the $90 support level with a range of $89.13 to $94.88...
by Raynovich Rod | Jun 3, 2024 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-2 Biopharma rally moves to SMID caps as momentum picks up ADPT, NVAX, TWST etc XBI over $93. Large caps steady with REGN over $1000. POST ASCO large cap core portfolio picks: ABBV, AZN, LLY, MRK, REGN. VRTX. Pfizer had good results but the stock could not...
by Raynovich Rod | May 20, 2024 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
UPDATE 3: Large cap biopharmas were strong on Friday in anticipation of #ASCO24 data. Company news to watch from data below:AZN, BMY, GILD, LLY, MRK, PFE,REGN and also ADPT, MRUS, NVS. REPL.. See updates all next week. Update-2 MAY 31,,,Biopharma stocks took a dip...
